Nordea julkaisi päivitetyn Terveystalo-analyysinsä. Suositus pysyy OSTA-tasolla, tavoitehinta nousee 13,00 euroon (edellinen: 11,80 €). 
Key downside risks: Increasing competition; availability and retention of key personnel; partnerships with insurance companies; and the outlook for occupational health and private healthcare services in a post-SOTE reform environment.
